SCHEMBL6490902

SCHEMBL6490902

OC1C/C=C\C[CH]Cc2ccccc2C1

nearest known ligand 0.36

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
ANPEP P15144 1/20 0.32
IDO1 P14902 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6480677 0.78 CYP19A1 (0.33) IDO1
SCHEMBL6480711 0.75
SCHEMBL6480553 0.72 CYP1A2 (0.45) ANPEP
SCHEMBL6480548 0.72 CYP1A2 (0.45) ANPEP
SCHEMBL73467 0.71 IDO1 (0.46) ANPEPIDO1
SCHEMBL29728630 0.71 IDO1 (0.46) ANPEPIDO1
SCHEMBL6490903 0.70 ANPEP (0.31) ANPEP
Ammonia Solution, Strong SCHEMBL7301670 0.69 IDO1 (0.44) ANPEPIDO1
Hydrochloric Acid SCHEMBL4151874 0.69 ANPEP (0.48) ANPEPIDO1
Methyl Alcohol SCHEMBL28162178 0.67 IDO1 (0.42) ANPEPIDO1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20050288238-A1 Benzocyclodecane derivatives with antitumor activity PFIZER INC 2005-12-29 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050288238-A1 Benzocyclodecane derivatives with antitumor activity H4C1; H4C2; H4C3; H4C4; H4C5; H4C6; H4C8; H4C9; H4C11; H4C12; H4C13; H4C14; H4C15; H4C16, OR10J3, BCL6 ANPEP 3551/4885IDO1 3806/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.